China Money Network
Login
Join

Chinese Molecular Diagnostics Firm GenomePrecision Raises Series B Round

  • February 19, 2019 — 17:09 CST

This Data Is Locked!

This area is available only to Subscribers.

Beijing GenomePrecision Technology Co., a Chinese precision medicine firm focused on molecular diagnostics, has raised a nearly RMB100 million (US$14.75 million) series B financing round... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: